期刊
GASTRIC CANCER
卷 22, 期 5, 页码 941-954出版社
SPRINGER
DOI: 10.1007/s10120-019-00932-0
关键词
H; pylori; Mucin 17; CEACAM1; CagA; Gastric cancer
资金
- National Natural Science Foundation of China [81872021, 81572346, 81772502]
- Natural Science Foundation of Beijing Municipality [7182027]
- National Key Research and Development Program of China [2017YFC1308900]
- Beijing Municipal Commission of Health and Family Planning Project [PXM2018_026279_000005]
- National Bio-Tech 863 Program [2012AA02A203]
- Beijing Nova Program [Z151100000315069]
- Beijing Talent Fund
- Beijing Municipal Administration of Hospitals Clinical Medicine Development of Special Funding Support [ZYLX201701]
- NATIONAL CANCER INSTITUTE [ZIABC010015] Funding Source: NIH RePORTER
Background and aims Helicobacter pylori invades the mucosal barrier and infects the mucins of gastric epithelial cells. However, whether gastric carcinogenesis caused by H. pylori infection involves the membrane-bound mucins is unclear. This study explored the role of mucin 17 (MUC17) in gastric cancer (GC) associated with H. pylori infection. Methods The expression of MUC17 and carcinoembryonic antigen-related cell adhesion molecule 1 (CEACAM1) was examined in human GC cells and tissues with H. pylori infection. Gain- and loss-of-function assays were performed to assess the role of MUC17 in regulating CEACAM1 in H. pylori-infected GC cells. Results MUC17 was downregulated in H. pylori-infected GC cells and tissues in association with poor survival of GC patients. Downregulation of MUC17 was attributable to MUC17 promoter methylation mediated by DNA methyltransferase 1 (DNMT1) H. pylori-enhanced GC cell proliferation and colony formation associated with MUC17 downregulation. Gain- and loss-of-function assays showed that MUC17 inhibited the H. pylori-enhanced GC cell growth by preventing the translocation of H. pylori CagA into GC cells. Moreover, MUC17 downregulated the expression of CEACAM1 variant 3S (CEACAM1-3S) in GC cells and tissues with H. pylori infection. Additionally, MUC17 downregulated CEACAM1 promoter activity via attenuation of NF-kappa B activation in GC cells. Conclusions MUC17 was epigenetically downregulated in GC with H. pylori infection. MUC17 inhibited H. pylori CagA translocation via attenuation of NF-kappa B-mediated expression of CEACAM1-3S in GC cells. Thus, MUC17 may serve as a valuable prognostic biomarker for H. pylori-associated GC.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据